Utilizing non-displaceable binding potential (BPND) quantification with 18F-Flutemetamol PET imaging can better assess amyloid pathology in elderly patients with low amyloid buildup compared to traditional standard uptake value ratio (SUVr), reported authors of an Oct. 12 study in the Journal of Nuclear Medicine. {read more here}